Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 39

    Article Cited by others

ORIGINAL ARTICLE

Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin d supplementation

Khayznikov Maksim, Hemachrandra Kallish, Pandit Ramesh, Kumar Ashwin, Wang Ping, Glueck Charles J

Year : 2015| Volume: 7| Issue : 3 | Page no: 86-93

   This article has been cited by
 
1 Statin-related myopathies
David Hilton-Jones
Practical Neurology. 2018; 18(2): 97
[Pubmed]  [Google Scholar] [DOI]
2 Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study
Zhenqiang Wu,Carlos A. Camargo,Kay-Tee Khaw,Debbie Waayer,Carlene M.M. Lawes,Les Toop,Robert Scragg
Atherosclerosis. 2018; 273: 59
[Pubmed]  [Google Scholar] [DOI]
3 Dyslipidaemia in the elderly: to treat or not to treat?
Niki Katsiki,Genovefa Kolovou,Pablo Perez-Martinez,Dimitri P. Mikhailidis
Expert Review of Clinical Pharmacology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen
Gerald Klose
MMW - Fortschritte der Medizin. 2018; 160(1): 40
[Pubmed]  [Google Scholar] [DOI]
5 Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases
Parth Shah
Current Cardiology Reports. 2018; 20(7)
[Pubmed]  [Google Scholar] [DOI]
6 Neurological Complications of Nutritional Deficiencies
Aparna Polavarapu,Daphne Hasbani
Seminars in Pediatric Neurology. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients
Leonardo Calza,Eleonora Magistrelli,Vincenzo Colangeli,Marco Borderi,Ilaria Contadini,Isabella Bon,Maria Carla Re,Pierluigi Viale
AIDS. 2017; 31(5): 681
[Pubmed]  [Google Scholar] [DOI]
8 Statin Use and 25-Hydroxyvitamin D Blood Level Response to Vitamin D Treatment of Older Adults
Heike A. Bischoff-Ferrari,Karina Fischer,Endel J. Orav,Bess Dawson-Hughes,Ursina Meyer,Patricia O. Chocano-Bedoya,Otto W. Meyer,Rahel Ernst,Simeon Schietzel,Franz Eberli,Hannes B. Staehelin,Gregor Freystätter,Susanne Roas,Robert Theiler,Andreas Egli,Nicholas M. Wilson
Journal of the American Geriatrics Society. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study
Parth Shah,Charles J. Glueck,Naila Goldenberg,Sarah Min,Chris Mahida,Ilana Schlam,Matan Rothschild,Ali Huda,Ping Wang
Lipids in Health and Disease. 2017; 16(1)
[Pubmed]  [Google Scholar] [DOI]
10 Trial designs for statin muscle intolerance
Robert S. Rosenson
Current Opinion in Lipidology. 2017; 28(6): 488
[Pubmed]  [Google Scholar] [DOI]
11 Statins Everyday Versus Alternate days: Is There a Difference in Myalgia rates?
Ramsha Riaz,Aleena Zehra Merchant,Muhammad Salman Ul Haq,Syed Ali Raza Nasir,Yusra Rizvi,Jehanzeb Ahmed Khan,Sara Mohiuddin Zakaria,Hassaan Jawed,Khizar Hamid,Noor-ul-ain Zehra,Madiha Ahmed,Hussain Asif Ali,Kaneez Fatima
Indian Heart Journal. 2017;
[Pubmed]  [Google Scholar] [DOI]
12 Vitamin D Deficiency, Supplementation, and Cardiovascular Health
Naveen Trehan,Luis Afonso,Diane L. Levine,Phillip D. Levy
Critical Pathways in Cardiology. 2017; 16(3): 109
[Pubmed]  [Google Scholar] [DOI]
13 Statins, Muscle Disease and Mitochondria
Radha Ramachandran,Anthony Wierzbicki
Journal of Clinical Medicine. 2017; 6(8): 75
[Pubmed]  [Google Scholar] [DOI]
14 Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort
Nikhil Sharma,Rachel Cooper,Diana Kuh
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
15 Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels
Rupinder Singh Buttar,Jasveen Batra,Jacqueline Kreimerman,Melissa Aleta,Michal L. Melamed
Journal of General Internal Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
16 Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study
Joshua Choi,Amir M Khan,Michael Jarmin,Naila Goldenberg,Charles J Glueck,Ping Wang
Lipids in Health and Disease. 2017; 16(1)
[Pubmed]  [Google Scholar] [DOI]
17 Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care
Susan E. Merel,Douglas S. Paauw
Journal of the American Geriatrics Society. 2017;
[Pubmed]  [Google Scholar] [DOI]
18 Practical aspects in the management of statin-associated muscle symptoms (SAMS)
Ulrich Laufs,Krysztof J. Filipiak,Ioanna Gouni-Berthold,Alberico L. Catapano,Giuseppe Mandraffino,Pascale Benlian
Atherosclerosis Supplements. 2017; 26: 45
[Pubmed]  [Google Scholar] [DOI]
19 Myotoxicity of statins: Mechanism of action
Patrick du Souich,Ghislaine Roederer,Robert Dufour
Pharmacology & Therapeutics. 2017;
[Pubmed]  [Google Scholar] [DOI]
20 Statin-related myotoxicity
Vera Fernandes,Maria Joana Santos,Antonio Pérez
Endocrinología y Nutrición (English Edition). 2016; 63(5): 239
[Pubmed]  [Google Scholar] [DOI]
21 Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
Parth Shah,Charles J. Glueck,Vybhav Jetty,Naila Goldenberg,Matan Rothschild,Rashid Riaz,Gregory Duhon,Ping Wang
Lipids in Health and Disease. 2016; 15(1)
[Pubmed]  [Google Scholar] [DOI]
22 Statin-related myotoxicity
Vera Fernandes,Maria Joana Santos,Antonio Pérez
Endocrinología y Nutrición. 2016;
[Pubmed]  [Google Scholar] [DOI]
23 Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol =70 mg/dl despite maximal tolerated cholesterol lowering therapy
Charles J. Glueck,Parth Shah,Naila Goldenberg,Marloe Prince,Kevin Lee,Vybhav Jetty,Ashwin Kumar,Michael Goldenberg,Ping Wang
Lipids in Health and Disease. 2016; 15(1)
[Pubmed]  [Google Scholar] [DOI]
24 Statin intolerance – a question of definition
Engi Abdel-Hady Algharably,Iris Filler,Stephanie Rosenfeld,Katja Grabowski,Reinhold Kreutz
Expert Opinion on Drug Safety. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
25 Lifestyle, Lipids, and Cardiovascular Risk Reduction in a Woman With Metabolically Unhealthy Normal Weight
Cynthia Geyer
American Journal of Lifestyle Medicine. 2016; 10(5): 348
[Pubmed]  [Google Scholar] [DOI]
26 Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol
Laura A. Della Badia,Nabil A. Elshourbagy,Shaker A. Mousa
Pharmacology & Therapeutics. 2016;
[Pubmed]  [Google Scholar] [DOI]
27 Current Use of Statins for Primary Prevention of Cardiovascular Disease: Patient-Reported Outcomes and Adherence
Scott A. Coon,Emily J. Ashjian,Megan C. Herink
Current Cardiovascular Risk Reports. 2016; 10(7)
[Pubmed]  [Google Scholar] [DOI]
28 Statin myopathy
Negar Maghsoodi,Anthony S. Wierzbicki
Current Opinion in Cardiology. 2016; 31(4): 417
[Pubmed]  [Google Scholar] [DOI]
29 Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons
Seema Patel
World Journal of Microbiology and Biotechnology. 2016; 32(5)
[Pubmed]  [Google Scholar] [DOI]
30 ¿Existe relación entre los niveles séricos de vitamina D (25OHD) y el dolor musculoesquelético relacionado con la ingesta de estatinas? Revisión sistemática
Claudia Alejandra Pereda,Maria Betina Nishishinya
Reumatología Clínica. 2016;
[Pubmed]  [Google Scholar] [DOI]
31 Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)1
Harold Bays,Shanu N. Kothari,Dan E. Azagury,John M. Morton,Ninh Nguyen,Peter H. Jones,Terry A. Jacobson,David Cohen,Carl Orringer,Eric C. Westman,Deborah B. Horn,Wendy Scinta,Craig Primack
Surgery for Obesity and Related Diseases. 2016;
[Pubmed]  [Google Scholar] [DOI]
32 Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
G. B. John Mancini,Steven Baker,Jean Bergeron,David Fitchett,Jiri Frohlich,Jacques Genest,Milan Gupta,Robert A. Hegele,Dominic Ng,Glen J. Pearson,Janet Pope,A. Yashar Tashakkor
Canadian Journal of Cardiology. 2016;
[Pubmed]  [Google Scholar] [DOI]
33 Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?
Amirhossein Sahebkar,Nikou Saboni,Matteo Pirro,Maciej Banach
Journal of Cachexia, Sarcopenia and Muscle. 2016;
[Pubmed]  [Google Scholar] [DOI]
34 Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain
Beth A. Taylor,Lindsay Lorson,Michael White,Paul D. Thompson
Atherosclerosis. 2016;
[Pubmed]  [Google Scholar] [DOI]
35 The Risks and Benefits of Sun Exposure 2016
David G. Hoel,Marianne Berwick,Frank R. de Gruijl,Michael F. Holick
Dermato-Endocrinology. 2016; : 00
[Pubmed]  [Google Scholar] [DOI]
36 Is There Really a Relationship Between Serum Vitamin D (25OHD) Levels and the Musculoskeletal Pain Associated With Statin Intake? A Systematic Review
Claudia Alejandra Pereda,Maria Betina Nishishinya
Reumatología Clínica (English Edition). 2016; 12(6): 331
[Pubmed]  [Google Scholar] [DOI]
37 Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon
Chandan Prasad,Victorine Imrhan,Shanil Juma,Mindy Maziarz,Anand Prasad,Casey Tiernan,Parakat Vijayagopal
Metabolites. 2015; 5(4): 733
[Pubmed]  [Google Scholar] [DOI]

 

Read this article